fingolimod hydrochloride has been researched along with Lymphomatoid Papulosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akay, EM; Cohen, SN; Evangelou, N; Samaraweera, AP | 1 |
| Cohen, V; Friedmann, D; Provost, N; Saber, M | 1 |
| Antoniou, C; Economidi, A; Karampidou, K; Katsavos, S; Marinos, L; Matoula, T; Nasis, G; Nikolaou, V; Stratigos, A | 1 |
3 other study(ies) available for fingolimod hydrochloride and Lymphomatoid Papulosis
| Article | Year |
|---|---|
Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphomatoid Papulosis; Multiple Sclerosis, Relapsing-Remitting; Skin Neoplasms | 2016 |
Lymphomatoid papulosis and fingolimod-A new connection?
Topics: Fingolimod Hydrochloride; Humans; Lymphomatoid Papulosis; Skin Neoplasms | 2016 |
Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
Topics: Fingolimod Hydrochloride; Humans; Lymphomatoid Papulosis; Multiple Sclerosis; Skin Neoplasms | 2016 |